Skip to main content
Erschienen in: Supportive Care in Cancer 9/2015

01.09.2015 | Original Article

How well is palliative care integrated into cancer care? A MASCC, ESMO, and EAPC Project

verfasst von: Mellar P. Davis, Florian Strasser, Nathan Cherny

Erschienen in: Supportive Care in Cancer | Ausgabe 9/2015

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The benefits of integration of palliative care into oncology have become evidence-based. How palliative care is perceived and structured in various settings and countries would be of interest.

Method

We used a previously published questionnaire to survey multiple institutions with members in MASCC and ESMO. The survey was made available on the MASCC website for approximately 6 months and repeated requests were made to complete the survey. Comparisons were made between NCI/ESMO designated cancer centers, nondesignated cancer centers, and urban hospitals.

Results

One hundred eighty-three different institutions completed this survey, 28 % of ESMO designated centers. Most institutions had palliative care programs and most programs consisted of an inpatient consult service and outpatient clinics. A minority had inpatient palliative care beds and institution supported hospice services. Barriers to palliative care were largely financial. Integration of palliative care into oncology was highly desirable but only a minority of respondents felt that their institution would financially support expanded services and additional palliative care personnel. Designated centers were more likely to have expanded palliative care services.

Discussion

Our findings are very similar to those previously published. Multiple studies have demonstrated that though palliative care integration into oncology is highly beneficial as measured by patient related outcomes, there is a great concern about reimbursement for services and budget constraints which prevent expansion of services.

Conclusion

Palliative care integration into cancer care is largely through consulting services for inpatients and outpatient clinics. Financial concerns limit integration and expansion of palliative care services. Designated cancer centers have more extensive palliative care services relative to nondesignated cancer centers and urban hospitals.
Literatur
1.
Zurück zum Zitat European Partnership Action Against Cancer Consensus G, Borras JM, Albreht T et al (2014) Policy statement on multidisciplinary cancer care. Eur J Cancer 50(3):475–480CrossRef European Partnership Action Against Cancer Consensus G, Borras JM, Albreht T et al (2014) Policy statement on multidisciplinary cancer care. Eur J Cancer 50(3):475–480CrossRef
2.
Zurück zum Zitat Greer JA, Jackson VA, Meier DE, Temel JS (2013) Early integration of palliative care services with standard oncology care for patients with advanced cancer. CA Cancer J Clin 63(5):349–363PubMedCrossRef Greer JA, Jackson VA, Meier DE, Temel JS (2013) Early integration of palliative care services with standard oncology care for patients with advanced cancer. CA Cancer J Clin 63(5):349–363PubMedCrossRef
3.
Zurück zum Zitat Temel JS, Greer JA, Muzikansky A et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363(8):733–742PubMedCrossRef Temel JS, Greer JA, Muzikansky A et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363(8):733–742PubMedCrossRef
4.
Zurück zum Zitat Centeno C (2014) International research: comparison and collaboration to understand and promote palliative care. Palliat Med 28(2):99–100PubMedCrossRef Centeno C (2014) International research: comparison and collaboration to understand and promote palliative care. Palliat Med 28(2):99–100PubMedCrossRef
5.
Zurück zum Zitat Hui D, Elsayem A, De la Cruz M et al (2010) Availability and integration of palliative care at US cancer centers. JAMA J Am Med Assoc 303(11):1054–1061CrossRef Hui D, Elsayem A, De la Cruz M et al (2010) Availability and integration of palliative care at US cancer centers. JAMA J Am Med Assoc 303(11):1054–1061CrossRef
6.
Zurück zum Zitat Miyashita M, Sanjo M, Morita T et al (2007) Barriers to providing palliative care and priorities for future actions to advance palliative care in Japan: a nationwide expert opinion survey. J Palliat Med 10(2):390–399PubMedCrossRef Miyashita M, Sanjo M, Morita T et al (2007) Barriers to providing palliative care and priorities for future actions to advance palliative care in Japan: a nationwide expert opinion survey. J Palliat Med 10(2):390–399PubMedCrossRef
7.
Zurück zum Zitat Hunt KJ, Shlomo N, Addington-Hall J (2013) End-of-life care and achieving preferences for place of death in England: results of a population-based survey using the VOICES-SF questionnaire. Pallia Med Hunt KJ, Shlomo N, Addington-Hall J (2013) End-of-life care and achieving preferences for place of death in England: results of a population-based survey using the VOICES-SF questionnaire. Pallia Med
8.
Zurück zum Zitat Patterson S, Trite J, Weaver T (2014) Activity and views of service users involved in mental health research: UK survey. Br J Psychiatry J Ment Sci Patterson S, Trite J, Weaver T (2014) Activity and views of service users involved in mental health research: UK survey. Br J Psychiatry J Ment Sci
9.
Zurück zum Zitat Mayland C, Lees C, West A, Cox T, Mason S, Ellershaw J (2014) Supporting patients and their families who wish to die at home—bereaved relatives’ views about the care and support received. BMJ Support Palliat Care 4(1):108CrossRef Mayland C, Lees C, West A, Cox T, Mason S, Ellershaw J (2014) Supporting patients and their families who wish to die at home—bereaved relatives’ views about the care and support received. BMJ Support Palliat Care 4(1):108CrossRef
10.
Zurück zum Zitat McPeake J, Bateson M, O’Neill A (2014) Electronic surveys: how to maximise success. Nurse Res 21(3):24–26PubMedCrossRef McPeake J, Bateson M, O’Neill A (2014) Electronic surveys: how to maximise success. Nurse Res 21(3):24–26PubMedCrossRef
11.
Zurück zum Zitat Woitha K, Van Beek K, Ahmed N et al (2014) Validation of quality indicators for the organization of palliative care: a modified RAND Delphi study in seven European countries (the Europall project). Palliat Med 28(2):121–129PubMedCrossRef Woitha K, Van Beek K, Ahmed N et al (2014) Validation of quality indicators for the organization of palliative care: a modified RAND Delphi study in seven European countries (the Europall project). Palliat Med 28(2):121–129PubMedCrossRef
12.
Zurück zum Zitat Pasman HR, Brandt HE, Deliens L, Francke AL (2009) Quality indicators for palliative care: a systematic review. J Pain Symptom Manag 38(1):145–156CrossRef Pasman HR, Brandt HE, Deliens L, Francke AL (2009) Quality indicators for palliative care: a systematic review. J Pain Symptom Manag 38(1):145–156CrossRef
13.
Zurück zum Zitat Nelson C, Chand P, Sortais J, Oloimooja J, Rembert G (2011) Inpatient palliative care consults and the probability of hospital readmission. Perm J 15(2):48–51PubMedCentralPubMedCrossRef Nelson C, Chand P, Sortais J, Oloimooja J, Rembert G (2011) Inpatient palliative care consults and the probability of hospital readmission. Perm J 15(2):48–51PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Fromme EK, Bascom PB, Smith MD et al (2006) Survival, mortality, and location of death for patients seen by a hospital-based palliative care team. J Palliat Med 9(4):903–911PubMedCrossRef Fromme EK, Bascom PB, Smith MD et al (2006) Survival, mortality, and location of death for patients seen by a hospital-based palliative care team. J Palliat Med 9(4):903–911PubMedCrossRef
15.
Zurück zum Zitat Starks H, Wang S, Farber S, Owens DA, Curtis JR (2013) Cost savings vary by length of stay for inpatients receiving palliative care consultation services. J Palliat Med 16(10):1215–1220PubMedCentralPubMedCrossRef Starks H, Wang S, Farber S, Owens DA, Curtis JR (2013) Cost savings vary by length of stay for inpatients receiving palliative care consultation services. J Palliat Med 16(10):1215–1220PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat Gomes B, Calanzani N, Curiale V, McCrone P, Higginson IJ (2013) Effectiveness and cost-effectiveness of home palliative care services for adults with advanced illness and their caregivers. Cochrane Database of Syst Rev 6:CD007760 Gomes B, Calanzani N, Curiale V, McCrone P, Higginson IJ (2013) Effectiveness and cost-effectiveness of home palliative care services for adults with advanced illness and their caregivers. Cochrane Database of Syst Rev 6:CD007760
17.
Zurück zum Zitat Ferrell BR (2005) Late referrals to palliative care. J Clin Oncol Off J Am Soc Clin Oncol 23(12):2588–2589CrossRef Ferrell BR (2005) Late referrals to palliative care. J Clin Oncol Off J Am Soc Clin Oncol 23(12):2588–2589CrossRef
18.
Zurück zum Zitat Von Roenn JH, Voltz R, Serrie A (2013) Barriers and approaches to the successful integration of palliative care and oncology practice. J Natl Compr Cancer Netw JNCCN 11(Suppl 1):S11–S16 Von Roenn JH, Voltz R, Serrie A (2013) Barriers and approaches to the successful integration of palliative care and oncology practice. J Natl Compr Cancer Netw JNCCN 11(Suppl 1):S11–S16
19.
Zurück zum Zitat Davis MP, Walsh D, LeGrand SB, Lagman RL, Harrison B, Rybicki L (2005) The financial benefits of acute inpatient palliative medicine: an inter-institutional comparative analysis by all patient refined-diagnosis related group and case mix index. J Support Oncol 3(4):313–316PubMed Davis MP, Walsh D, LeGrand SB, Lagman RL, Harrison B, Rybicki L (2005) The financial benefits of acute inpatient palliative medicine: an inter-institutional comparative analysis by all patient refined-diagnosis related group and case mix index. J Support Oncol 3(4):313–316PubMed
20.
Zurück zum Zitat Parikh RB, Kirch RA, Smith TJ, Temel JS (2013) Early specialty palliative care-translating data in oncology into practice. N Engl J Med 369(24):2347–2351PubMedCentralPubMedCrossRef Parikh RB, Kirch RA, Smith TJ, Temel JS (2013) Early specialty palliative care-translating data in oncology into practice. N Engl J Med 369(24):2347–2351PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Verret D, Rohloff RM (2013) The value of palliative care. Healthc Financ Manag J Healthc Financ Manag Assoc 67(3):50–54 Verret D, Rohloff RM (2013) The value of palliative care. Healthc Financ Manag J Healthc Financ Manag Assoc 67(3):50–54
22.
Zurück zum Zitat Parsons HA, Baracos VE, Dhillon N, Hong DS, Kurzrock R (2012) Body composition, symptoms, and survival in advanced cancer patients referred to a phase I service. PLoS One 7(1):e29330PubMedCentralPubMedCrossRef Parsons HA, Baracos VE, Dhillon N, Hong DS, Kurzrock R (2012) Body composition, symptoms, and survival in advanced cancer patients referred to a phase I service. PLoS One 7(1):e29330PubMedCentralPubMedCrossRef
23.
Zurück zum Zitat Hui D, Parsons H, Nguyen L et al (2010) Timing of palliative care referral and symptom burden in phase 1 cancer patients: a retrospective cohort study. Cancer 116(18):4402–4409PubMedCentralPubMedCrossRef Hui D, Parsons H, Nguyen L et al (2010) Timing of palliative care referral and symptom burden in phase 1 cancer patients: a retrospective cohort study. Cancer 116(18):4402–4409PubMedCentralPubMedCrossRef
Metadaten
Titel
How well is palliative care integrated into cancer care? A MASCC, ESMO, and EAPC Project
verfasst von
Mellar P. Davis
Florian Strasser
Nathan Cherny
Publikationsdatum
01.09.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 9/2015
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-2630-z

Weitere Artikel der Ausgabe 9/2015

Supportive Care in Cancer 9/2015 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.